Navigation Links
Data Show FLECTOR(R) Patch Yields Significant Pain Reduction for Acute Strains, Sprains and Contusions
Date:5/8/2008

3 countries. FLECTOR(R) Patch has been used in more than six million patients with a total of approximately 175 million patches dispensed.

Important Safety Information

Cardiovascular risk

-- NSAIDs may cause an increased risk of serious cardiovascular thrombotic

events, myocardial infarction, and stroke, which can be fatal. This

risk may increase with duration of use. Patients with cardiovascular

disease or risk factors for cardiovascular disease may be at greater

risk.

-- FLECTOR(R) Patch is contraindicated for the treatment of peri-operative

pain in the setting of coronary artery bypass graft (CABG) surgery.

Gastrointestinal risk

-- NSAIDs cause an increased risk of serious gastrointestinal adverse

events including bleeding, ulceration, and perforation of the stomach

or intestines, which can be fatal. These events can occur at any time

during use and without warning symptoms. Elderly patients are at

greater risk for serious gastrointestinal events.

Carefully consider the potential benefits and risks of FLECTOR(R) Patch and other treatment options before deciding to use FLECTOR(R) Patch.

FLECTOR(R) Patch is contraindicated in patients with known hypersensitivity to diclofenac. FLECTOR(R) Patch should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients.

Use the lowest effective dose for the shortest duration consistent with individual patient treatment goals.

FLECTOR(R) Patch should not be applied to non-intact or damaged skin resulting from any etiology, eg, exudative dermatitis, eczema, infected lesion, burns or wounds.

NSAIDs, including FLECTOR(R) Patch, can cause serious skin adverse events such as exfoliative dermatitis, Stevens
'/>"/>

SOURCE Alpharma Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. New Analysis in Boys and Girls Shows the ADHD Patch, DAYTRANA(TM) (methylphenidate transdermal system), Offered ADHD Symptom Control for 12 Months
2. Genetic Immunity Announces Data Related to the DermaVir Nanomedicine Patch in the Journal of Immunology
3. Iomai Receives HHS Approval to Begin Phase 2 Trial of H5N1 Influenza Adjuvant Patch
4. Iomai and Merck & Co., Inc. Evaluate Use of Iomai Immunostimulant Patch
5. Genetic Immunity Presents Clinical Data on DermaVir Patch Immune Therapy at 15th Annual Conference on Retroviruses and Opportunistic Infections
6. Cerimon Pharmaceuticals Initiates Phase II/III Clinical Studies to Evaluate its Diclofenac Patch for Mild to Moderate Pain
7. Long-Term 12-Month Safety Data Presented on ADHD Patch DAYTRANA(TM) (methylphenidate transdermal system)
8. Cerimon Pharmaceuticals Initiates Phase I Clinical Study of Topical Diclofenac Sodium Patch
9. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
10. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
11. Use of PressureWire(R) Yields a More Accurate Assessment of Translesion Pressure Gradients in Peripheral Vasculature, Two New Studies Report
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/13/2008)...ta Tuesday, May 13 at 1:00 p.m. EDT ...nd MENLO PARK, Calif., May 13 /PRNewswire-FirstCal... positive six-month follow-up,data from the CUSTOM...,efficacy of the Custom NX(R) drug eluting stent (...onary artery disease., The CUSTOM III clinical tr...
(Date:5/13/2008)...lowing Success with 8 Patients, PRINCETON, N.J., ...TC,Bulletin Board: DSCI), a provider of advanced w...f cardiovascular and thoracic surgeons from the,Un...(TM) dressings to,successfully treat 8 patients wi...on that sometimes arises after open-heart surgerie...
(Date:5/13/2008)...- USHIFU, LLC, the clinical trial,management provi... pleased,to announce conditional written approval ... to begin a pivotal trial for the treatment of,rec...n men who have failed,external beam radiation ther...YU School of Medicine and,medical monitor for the ...
(Date:5/13/2008)... New soluble polymer material,designed to stop bon...ling,according to a new animal study just publish...ndings come on the heels of recently published,res...lower the risk of,surgical infections., Researche...t Charleston,and Keck School of Medicine at the Un...
Breaking Medicine Technology:XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting 2XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting 3XTENT Announces Positive Six-Month CUSTOM III Trial Data Presented at EuroPCR Meeting 4Cardiovascular Researchers Use MEDIHONEY(TM) on Sternal Infections Following Open-Heart Procedures 2Cardiovascular Researchers Use MEDIHONEY(TM) on Sternal Infections Following Open-Heart Procedures 3FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer 2Ceremed's OSTENE(R) Improves Bone Fusion and Healing After Surgery, New Study Shows 2Ceremed's OSTENE(R) Improves Bone Fusion and Healing After Surgery, New Study Shows 3Researchers Use Magnetism to Target Cells to Animal Arteries 1156 1Researchers Use Magnetism to Target Cells to Animal Arteries 1156 2Researchers Use Magnetism to Target Cells to Animal Arteries 1156 3Researchers Use Magnetism to Target Cells to Animal Arteries 1156 4More sun exposure may be good for some people 9188 1More sun exposure may be good for some people 9188 2More sun exposure may be good for some people 9188 3Team Finds 118 Genes That Might Play Role in Cancer 9186 1Team Finds 118 Genes That Might Play Role in Cancer 9186 2Rockefeller Universitys Center for Clinical and Translational Science funds pilot studies 9184 1Rockefeller Universitys Center for Clinical and Translational Science funds pilot studies 9184 2
(Date:5/13/2008)...drew Raguskus to Serve as Senior Technology Adviso...-- The Board of Directors,of Sonic Innovations, In...d,digital hearing aids, today announced that Andre...rd. Mr. Raguskus will continue as a member of the,...ogy Advisor. As a result,of Mr. Raguskus, announce...
(Date:5/13/2008)...ealty Investment Trust invites Foundation to celeb...er life for people with CF,, BETHESDA, Md., Ma...kable progress in treating cystic fibrosis -- a fa...rust invited the Cystic Fibrosis Foundation,to joi...ock Exchange (NYSE),today., Life expectancy for...
(Date:5/13/2008)...ts as often as whites, researchers not sure why di...TUESDAY, May 13 (HealthDay News) -- Even though bl...referral rates to oncologists, blacks are less lik...new research shows. , In their study, researche...ancer Center looked at 2,582 white patients and 13...
(Date:5/13/2008)... helps prevent the disease, two additional studies...ay News) -- New research has found both bad news a...news is a risk factor you can,t change: Women whos...n increased risk of breast cancer throughout their...sis, according to a study in the May 13 issue of t...
Breaking Medicine News(10 mins):Health News:Sam Westover to Serve as Chairman of the Board and Chief Executive Officer for Sonic Innovations 2Health News:Sam Westover to Serve as Chairman of the Board and Chief Executive Officer for Sonic Innovations 3Health News:Cystic Fibrosis Foundation President Rings Bell to Close New York Stock Exchange 2Health News:Black Rectal Cancer Patients Less Likely to Get Chemo, Radiation 2Health News:Familial Breast Cancer Risk Lasts a Lifetime for Sisters 2Health News:Familial Breast Cancer Risk Lasts a Lifetime for Sisters 3
...lt hair follicles undergo a growth cycle consistin...en), and rest (telogen). Researchers demonstrated ...en-phase adult hair follicles is sufficient to ini... that the transient activation of a protein called...
...hma is one of the most common chronic conditions a...dy shows children who have multiple ear // infecti...osed with asthma. The study included 7,538 childre...te medical history for each child was reviewed, as...
... all vitamins may be good for you. A new study sho...ease, antioxidant vitamins, such as // E, C and be...bad” form of cholesterol. Some studies have shown ...of the lipoprotein-breakdown pathway in rat and mo...
...imates show white children under age 2 who were sp... risk of behavior problems that // required a pare...to children who were not spanked. However, the lin...s in black and Hispanic children was not significa...
Other Medicine News:Health News:New Hair in 15 Days Could Now Be A Possibility Say Researchers 2
The InTray™ GC is a novel device for the growth and detection of both Neisseria gonorrhoeae and Neisseria meningitidis. This product provides a long shelf life and is easily transportable as a
...logies has developed laser thermal keratoplasty (L...2000 for the temporary reduction of hyperopia from... older with up to 0.75 diopters of astigmatism and...Unlike most refractive surgery, LTK is not perform...
...amily of infrared laser photocoagulators includes ...de lasers serve as a single laser source for multi...regular maintenance or special electrical/cooling,...n. The OcuLight SLx is now available with Tri-Mode...
Danker Laboratories manufacturers a wide variety of RGP orthokeratology lenses (also known as "Reverse Geometry" or "Corneal Reshaping" Lenses) according to the custom specifications and demanding st
Medicine Products: